Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines about artificial intelligence. Everyone's talking about AI right now. But see, I've been talking about it for years.

I call it my AI Retirement Playbook. I recommend you check it out now.

Brian Young Biography and Net Worth

Insider of Novanta

rian S. Young serves as Chief Human Resource Officer of the Company. Mr. Young brings more than 20 years of human resources leadership experience in both public and private companies serving Original Equipment Manufacturers (“OEMs”) of Class I, II & III medical devices, industrial control technology and advanced materials. From July 2014 to March 2015, Mr. Young served as Global Human Resource Leader for Hollingsworth & Vose Company. From September 2011 to November 2013, Mr. Young served as Vice President & Human Resource Officer for CIRCOR International, Inc. From September 2010 to August 2011, Mr. Young served as Director Total Rewards for CIRCOR. In addition, from June 2003 to August 2010, Mr. Young served in various leadership roles with Lake Region Medical (formerly Accellent, Inc.). Mr. Young’s early career experience was in General Human Resource Management with a specialization in training and development. Mr. Young holds a Bachelor of Science Degree in Administration of Justice from Pennsylvania State University.

What is Brian S. Young's net worth?: The estimated net worth of Brian S. Young is at least $5.15 million as of February 2nd, 2023. Mr. Young owns 33,539 shares of Novanta stock worth more than $5,148,237 as of December 21st. This net worth evaluation does not reflect any other assets that Mr. Young may own. Additionally, Mr. Young receives a salary of $540,200.00 as Insider at Novanta. Learn More about Brian S. Young's net worth.
How old is Brian S. Young?: Mr. Young is currently 55 years old. There are 3 older executives and no younger executives at Novanta. The oldest executive at Novanta is Mr. Peter L. Chang, Corporate Controller & Chief Accounting Officer, who is 59 years old. Learn More on Brian S. Young's age.
What is Brian S. Young's salary?: As the Insider of Novanta Inc., Mr. Young earns $540,200.00 per year. There are 3 executives that earn more than Mr. Young. The highest earning executive at Novanta is Mr. Matthijs Glastra, Chairman and CEO, who commands a salary of $1,600,000.00 per year. Learn More on Brian S. Young's salary.
How do I contact Brian S. Young?: The corporate mailing address for Mr. Young and other Novanta executives is 125 Middlesex Turnpike, Bedford MA, 01730. Novanta can also be reached via phone at (781) 266-5700 and via email at [email protected]. Learn More on Brian S. Young's contact information.
Has Brian S. Young been buying or selling shares of Novanta?: Brian S. Young has not been actively trading shares of Novanta within the last three months. Most recently, Brian S. Young sold 6,000 shares of the business's stock in a transaction on Thursday, February 2nd. The shares were sold at an average price of $170.93, for a transaction totalling $1,025,580.00. Following the completion of the sale, the insider now directly owns 33,539 shares of the company's stock, valued at $5,732,821.27. Learn More on Brian S. Young's trading history.
Who are Novanta's active insiders?: Novanta's insider roster includes Robert Buckley (CFO), Peter Chang (CAO), Matthijs Glastra (Chairman and CEO), Thomas Secor (Director), and Brian Young (Insider). Learn More on Novanta's active insiders.
Are insiders buying or selling shares of Novanta?: In the last twelve months, insiders at the technology company sold shares 16 times. They sold a total of 47,334 shares worth more than $8,095,377.39. The most recent insider tranaction occured on November, 11th when CEO Matthijs Glastra sold 7,500 shares worth more than $1,347,750.00. Insiders at Novanta own 1.2% of the company. Learn More about insider trades at Novanta.
Information on this page was last updated on 11/11/2024.

Brian S. Young Insider Trading History at Novanta

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/2/2023	Sell	6,000	$170.93	$1,025,580.00	33,539
12/28/2020	Sell	6,741	$120.40	$811,616.40	13,901
5/12/2020	Sell	8,950	$95.00	$850,250.00	15,501

Brian S. Young Buying and Selling Activity at Novanta

Novanta Company Overview

Novanta, Inc. engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products. The Vision segment offers a range of medical grade technologies, including medical insufflators, pumps and related disposables, surgical displays and operating room integration technologies, optical data collection and machine vision technologies, radio frequency identification technologies, thermal printers, spectrometry technologies, and embedded touch screen solutions. The Precision Motion segment includes optical encoders, precision motor and motion control technology, air bearing spindles, and precision machined components to customers. The company was founded in 1968 and is headquartered in Bedford, MA.

Today's Range

Now: $153.50

$151.03

$155.28

50 Day Range

MA: $170.15

$153.46

$182.65

2 Week Range

Now: $153.50

$146.86

$187.12

Volume

575,317 shs

Average Volume

150,320 shs

Market Capitalization

$5.51 billion

P/E Ratio

91.92

Dividend Yield

N/A

Beta

1.26

Most People Are Dead Wrong.

From Brownstone Research | Ad

I call it my AI Retirement Playbook. I recommend you check it out now.

Brian Young Biography and Net Worth

What is Brian S. Young's net worth?

How old is Brian S. Young?

What is Brian S. Young's salary?

How do I contact Brian S. Young?

Has Brian S. Young been buying or selling shares of Novanta?

Who are Novanta's active insiders?

Are insiders buying or selling shares of Novanta?